3Brien R J O, Nunn 99. The need for druags agents tuberculosis obstacles,opportunities, and next steps Am J Respire Crit Care Mea, 2001,163(5) : 1055.
4Jarvis B, Lamb H M. Rifapentine Drugs 1998,56.607.
5Brogden R N, Futon A, Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy Drugs, 1994,47: 983.
6Alvirez- Freites E J,Carter J L,Cynamon M H. In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis Antimicrob Agents. Chemother, 2002,46:1022.
7Miyazaki E,Miyzaki M, Chen J M, et al. Moxifloxacin (Bay 12.8039), a new 8 - melhoxyquindone, is active in a mouse model of tuberculosis Antimicrob Agents Chemother, 1999,43 : 85.
8Koletra S L,Berry A J, Cynamon M H, et al. Azithromyein as treatment for disseminated Mycobacrerium avium complex in AIDS patients Antimicrob Agents Chemother, 1999, 43: 2867.
9Iseman M D. Tuberculosis therapy: Past, present and future Eur Respir J,2002,20 (Supp 136) : 87s.
10Stover C K, Warrener P. Donald R,et al.A smallmolecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature, 2000,405:962.
